Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and ElectronicsBusiness Overview: ASE is a pharmaceutical health care companies, which through its group companies, manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and abroad
Ambalal Sarabhai Enterprises' board has approved the financial results for the quarter ended June 30, 2025. The company reported a consolidated net profit of Rs 8.22 Cr on revenue from operations of Rs 40.34 Cr, with consolidated EPS at Rs 1.07. Additionally, the board has constituted a Pharma Committee of...
Ambalal Sarabhai Enterprises Limited has announced a board meeting to approve the financial results for the quarter and half-year. The Board approved the audited consolidated and standalone financial results for the year ended March 31, 2025, reporting consolidated revenue of ₹196.19 Cr and net profit of ₹4.93 Cr. Electronics segment...
